Research Publications

Evidence-based research driving better outcomes for TB patients across Namibia and the region.

Science in Service of People

Our research informs policy, shapes programmes, and ensures that decisions about TB care are rooted in evidence and lived experience.

Epidemiology 2024

TB Treatment Outcomes in Namibia: A Five-Year Review (2019–2024)

Husselmann K., et al.

African Journal of Respiratory Medicine

This study reviews TB treatment success rates across Namibia's 14 regions, identifying key disparities in outcomes by geography, gender, and HIV co-infection status.

Community Health 2024

Community-Based TB Detection: Lessons from Northern Namibia

TB Free Foundation of Namibia

TB Free Foundation Report

An evaluation of community-led TB screening initiatives in the Oshana and Ohangwena regions, exploring feasibility, yield, and cost-effectiveness.

Social Science 2023

Stigma and TB Treatment Adherence: A Qualitative Study

Husselmann K., Nakale T.

International Journal of TB and Lung Disease

This qualitative research explores the relationship between TB-related stigma and treatment non-adherence among patients in urban and peri-urban Namibia.

Policy 2023

Drug-Resistant TB in Sub-Saharan Africa: Policy Implications

TB Free Foundation Consortium

Lancet Regional Health – Africa

A policy analysis examining the structural, financial, and healthcare system factors driving the rise of MDR-TB in sub-Saharan Africa, with specific focus on Namibia.

Gender & Health 2022

Gender and TB: Why Women Face Unique Barriers to Diagnosis

Husselmann K., et al.

Global Health: Science and Practice

This paper examines gender-specific barriers to TB diagnosis and care, drawing on data from Namibia and recommending targeted interventions for women and girls.

Paediatrics 2022

Paediatric TB in Namibia: Gaps in Diagnosis and Treatment

TB Free Foundation of Namibia

TB Free Foundation Report

An assessment of paediatric TB burden in Namibia, highlighting diagnostic gaps, under-reporting, and the need for child-friendly treatment formulations.

Collaborate With Us

We welcome research partnerships with universities, health institutions, and international organisations committed to ending TB.

Get in Touch